US Stock MarketDetailed Quotes

BCTX BriaCell Therapeutics

Watchlist
  • 2.240
  • +0.050+2.28%
Close Apr 25 16:00 ET
  • 2.320
  • +0.080+3.57%
Post 18:25 ET
35.80MMarket Cap-2835P/E (TTM)

BriaCell Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2024
(Q1)Oct 31, 2023
(FY)Jul 31, 2023
(Q4)Jul 31, 2023
(Q3)Apr 30, 2023
(Q2)Jan 31, 2023
(Q1)Oct 31, 2022
(FY)Jul 31, 2022
(Q4)Jul 31, 2022
(Q3)Apr 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
119.10%9.83M
57.37%8.5M
52.25%23.27M
47.22%7.71M
37.68%5.68M
23.13%4.49M
136.48%5.4M
119.23%15.29M
228.12%5.23M
-14.22%4.12M
Selling and administrative expenses
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
52.43%2.15M
46.67%7.27M
100.60%2.07M
-49.57%1.85M
-General and administrative expense
9.70%1.57M
-23.38%1.65M
9.19%7.94M
22.91%2.54M
-2.05%1.82M
-26.08%1.43M
52.43%2.15M
46.67%7.27M
100.60%2.07M
-49.57%1.85M
Research and development costs
170.44%8.26M
110.65%6.86M
91.19%15.34M
63.07%5.17M
70.16%3.86M
78.75%3.05M
271.75%3.26M
296.93%8.02M
445.59%3.17M
101.60%2.27M
Other operating expenses
----
----
----
----
----
----
----
8.21%-3.39K
--0
----
Operating profit
-119.10%-9.83M
-57.37%-8.5M
-52.25%-23.27M
-47.22%-7.71M
-37.68%-5.68M
-23.13%-4.49M
-136.48%-5.4M
-119.23%-15.29M
-228.12%-5.23M
14.22%-4.12M
Net non-operating interest income expense
-66.09%81.6K
1.31%190.82K
556.50%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
3,436.48%188.35K
280.03%135.75K
69.73%82.36K
157.66%35.99K
Non-operating interest income
-66.09%81.6K
1.31%190.82K
551.80%891.21K
153.50%208.78K
604.39%253.49K
1,891.52%240.6K
2,887.36%188.35K
4,242.05%136.73K
2,515.37%82.36K
--35.99K
Non-operating interest expense
----
----
--0
--0
--0
----
----
-98.75%979
--0
--0
Other net income (expense)
79.23%-1.59M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
116.27%4.11M
-72.70%-11.69M
132.29%4.7M
-175.82%-5.93M
Gain on sale of security
79.47%-1.57M
247.38%14.27M
117.78%2.08M
8.02%5.08M
108.91%528.1K
-151.62%-7.64M
116.27%4.11M
-76.39%-11.69M
132.15%4.7M
-174.15%-5.93M
Earnings from equity interest
---18.35K
----
----
----
----
--0
----
----
----
----
Income before tax
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
-439.55%-10.02M
Income tax
Net income
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
-439.55%-10.02M
Net income continuous Operations
4.61%-11.33M
638.51%5.96M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
-439.55%-10.02M
Minority interest income
-39.31K
-42.67K
0
0
Net income attributable to the parent company
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
-439.55%-10.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.94%-11.29M
642.37%6M
24.35%-20.3M
-437.06%-2.42M
51.12%-4.9M
-206.46%-11.88M
95.98%-1.11M
-94.26%-26.84M
97.20%-450.35K
-439.55%-10.02M
Basic earnings per share
7.79%-0.71
642.86%0.38
24.86%-1.3
-400.00%-0.15
50.77%-0.32
-208.45%-0.77
96.13%-0.07
43.46%-1.73
97.16%-0.03
-203.17%-0.65
Diluted earnings per share
7.79%-0.71
-614.29%-0.5
24.86%-1.3
-400.00%-0.15
50.77%-0.32
-208.45%-0.77
96.13%-0.07
43.46%-1.73
97.16%-0.03
-203.17%-0.65
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jan 31, 2024(Q1)Oct 31, 2023(FY)Jul 31, 2023(Q4)Jul 31, 2023(Q3)Apr 30, 2023(Q2)Jan 31, 2023(Q1)Oct 31, 2022(FY)Jul 31, 2022(Q4)Jul 31, 2022(Q3)Apr 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 119.10%9.83M57.37%8.5M52.25%23.27M47.22%7.71M37.68%5.68M23.13%4.49M136.48%5.4M119.23%15.29M228.12%5.23M-14.22%4.12M
Selling and administrative expenses 9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M52.43%2.15M46.67%7.27M100.60%2.07M-49.57%1.85M
-General and administrative expense 9.70%1.57M-23.38%1.65M9.19%7.94M22.91%2.54M-2.05%1.82M-26.08%1.43M52.43%2.15M46.67%7.27M100.60%2.07M-49.57%1.85M
Research and development costs 170.44%8.26M110.65%6.86M91.19%15.34M63.07%5.17M70.16%3.86M78.75%3.05M271.75%3.26M296.93%8.02M445.59%3.17M101.60%2.27M
Other operating expenses ----------------------------8.21%-3.39K--0----
Operating profit -119.10%-9.83M-57.37%-8.5M-52.25%-23.27M-47.22%-7.71M-37.68%-5.68M-23.13%-4.49M-136.48%-5.4M-119.23%-15.29M-228.12%-5.23M14.22%-4.12M
Net non-operating interest income expense -66.09%81.6K1.31%190.82K556.50%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K3,436.48%188.35K280.03%135.75K69.73%82.36K157.66%35.99K
Non-operating interest income -66.09%81.6K1.31%190.82K551.80%891.21K153.50%208.78K604.39%253.49K1,891.52%240.6K2,887.36%188.35K4,242.05%136.73K2,515.37%82.36K--35.99K
Non-operating interest expense ----------0--0--0---------98.75%979--0--0
Other net income (expense) 79.23%-1.59M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M116.27%4.11M-72.70%-11.69M132.29%4.7M-175.82%-5.93M
Gain on sale of security 79.47%-1.57M247.38%14.27M117.78%2.08M8.02%5.08M108.91%528.1K-151.62%-7.64M116.27%4.11M-76.39%-11.69M132.15%4.7M-174.15%-5.93M
Earnings from equity interest ---18.35K------------------0----------------
Income before tax 4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K-439.55%-10.02M
Income tax
Net income 4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K-439.55%-10.02M
Net income continuous Operations 4.61%-11.33M638.51%5.96M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K-439.55%-10.02M
Minority interest income -39.31K-42.67K00
Net income attributable to the parent company 4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K-439.55%-10.02M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.94%-11.29M642.37%6M24.35%-20.3M-437.06%-2.42M51.12%-4.9M-206.46%-11.88M95.98%-1.11M-94.26%-26.84M97.20%-450.35K-439.55%-10.02M
Basic earnings per share 7.79%-0.71642.86%0.3824.86%-1.3-400.00%-0.1550.77%-0.32-208.45%-0.7796.13%-0.0743.46%-1.7397.16%-0.03-203.17%-0.65
Diluted earnings per share 7.79%-0.71-614.29%-0.524.86%-1.3-400.00%-0.1550.77%-0.32-208.45%-0.7796.13%-0.0743.46%-1.7397.16%-0.03-203.17%-0.65
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg